ArticleMolecular carcinogenesis2023

The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.